Article Information
History
- July 2, 2019.
Article Versions
- Version 1 (July 1, 2019 - 09:20).
- You are currently viewing Version 2 of this article (July 2, 2019 - 18:43).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Xiaoyu Shi1,8,
- Qi Li1,2,8,
- Zhipeng Dai3,
- Arthur A. Tran4,
- Siyu Feng5,
- Alejandro D. Ramirez1,
- Zixi Lin1,
- Xiaomeng Wang1,
- Tracy T. Chow6,
- Ian B. Seiple1,2,* and
- Bo Huang1,6,7,*
- 1Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94143 USA
- 2Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143 USA
- 3Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA 94143 USA
- 4Graduate Program in Chemistry and Chemical Biology, University of California, San Francisco, San Francisco, CA 94143 USA
- 5UC Berkeley – UCSF Joint Graduate Program in Bioengineering, University of California, San Francisco, San Francisco, CA 94143 USA
- 6Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94143 USA
- 7Chan Zuckerberg Biohub, San Francisco, CA 94158 USA
- ↵#Corresponding author; email: bo.huang{at}ucsf.edu
↵8 These authors contributed equally: Xiaoyu Shi, Qi Li